US Lends More Support towards Ebola Response with Advanced Treatments

Building on sustained U.S. technical support to Uganda since the first day of the 2025 Ebola outbreak, the United States government has now donated 100 vials of monoclonal antibodies to the Uganda Ministry of Health.

As a breakthrough in medical science, monoclonal antibodies have the potential to significantly improve survival rates in patients with Ebola and will enhance the strong ongoing efforts to end the current Sudan Ebola Virus (SUDV) outbreak in Uganda.

U.S. Ambassador William W. Popp handed over the treatments to State Minister for Health, General Duties, Anifa Kawooya Bangirana, at the National Medical Stores where they will be safely stored until needed in the event of future cases.

On the 19^th of March, The Ministry of Health started a 42-day countdown to officially declare Uganda Ebola-free after two more patients recovered and were discharged from treatment facilities.

According to the Ministry, since the outbreak was declared on January 30, 2025, Uganda has recorded 12 confirmed cases of Ebola. Out of these, 10 patients have recovered, while two have died.

The vials of monoclonal antibodies are viable for years under specified temperature conditions. Previously, during the 2022 outbreak, the U.S. government donated monoclonal antibodies for compassionate use in the successful management of the SUDV outbreak in Mubende.

“The United States’ donation of monoclonal antibodies is an important contribution to the global fight against Ebola, saving lives in Uganda, and making both America and Uganda safer,” said Ambassador Popp.

He added, “Providing these groundbreaking treatments demonstrates the United States’ strong commitment to innovation, scientific excellence, shared prosperity, and global health security. As we respond to outbreaks like Ebola, we build stronger global health security partnerships that benefit us all.”

The additional monoclonal antibody therapy is a timely donation ensuring health authorities are ready to promptly manage any new confirmed cases as Uganda progresses on the countdown to end the 2025 Ebola outbreak.

This U.S. government assistance is in addition to ongoing robust U.S. contributions to Uganda’s 2025 Ebola response, including more than $6 million to date to support case identification and surveillance, contact tracing, lab diagnostics, entry/exit screening, public messaging, community outreach, and infection prevention and control.